
Michael P. Barker
Examiner (ID: 19383, Phone: (571)272-0303 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1655, OPQA |
| Total Applications | 1330 |
| Issued Applications | 1017 |
| Pending Applications | 61 |
| Abandoned Applications | 256 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16188510
[patent_doc_number] => 20200229359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => CANNABIS FARMING METHODS
[patent_app_type] => utility
[patent_app_number] => 16/827579
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 463
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827579 | Cannabis farming methods | Mar 22, 2020 | Issued |
Array
(
[id] => 16320192
[patent_doc_number] => 10780139
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-09-22
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/823808
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 7516
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823808 | None | Mar 18, 2020 | Issued |
Array
(
[id] => 18801304
[patent_doc_number] => 11834455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Carm1 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/822478
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 66911
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 531
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/822478 | Carm1 inhibitors and uses thereof | Mar 17, 2020 | Issued |
Array
(
[id] => 18801304
[patent_doc_number] => 11834455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Carm1 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/822478
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 66911
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 531
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/822478 | Carm1 inhibitors and uses thereof | Mar 17, 2020 | Issued |
Array
(
[id] => 16374993
[patent_doc_number] => 20200323835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => TREATMENT FOR DOPAMINERGIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/788463
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788463 | TREATMENT FOR DOPAMINERGIC DISORDERS | Feb 11, 2020 | Abandoned |
Array
(
[id] => 16189284
[patent_doc_number] => 20200230133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => Discrete PEG Constructs
[patent_app_type] => utility
[patent_app_number] => 16/785693
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785693 | Discrete PEG Constructs | Feb 9, 2020 | Abandoned |
Array
(
[id] => 16990097
[patent_doc_number] => 20210228517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => ANTICANCER DRUG EFFECT ENHANCER
[patent_app_type] => utility
[patent_app_number] => 17/267337
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267337
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267337 | Anticancer drug effect enhancer | Feb 4, 2020 | Issued |
Array
(
[id] => 18642424
[patent_doc_number] => 11766477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Methods for making mixed allergen compositions
[patent_app_type] => utility
[patent_app_number] => 16/750522
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10084
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750522 | Methods for making mixed allergen compositions | Jan 22, 2020 | Issued |
Array
(
[id] => 16153583
[patent_doc_number] => 20200215024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => CANNABINOID FORMULATIONS FOR TREATING ALCOHOL HANGOVER
[patent_app_type] => utility
[patent_app_number] => 16/737413
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737413
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737413 | CANNABINOID FORMULATIONS FOR TREATING ALCOHOL HANGOVER | Jan 7, 2020 | Abandoned |
Array
(
[id] => 15862593
[patent_doc_number] => 20200138700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => HYPOTONIC MICROBICIDAL FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/717570
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717570
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/717570 | Hypotonic microbicidal formulations and methods of use | Dec 16, 2019 | Issued |
Array
(
[id] => 16892007
[patent_doc_number] => 11033533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => (2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
[patent_app_type] => utility
[patent_app_number] => 16/715722
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 21739
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/715722 | (2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Dec 15, 2019 | Issued |
Array
(
[id] => 15765893
[patent_doc_number] => 20200113964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALOPECIA COMPRISING EREMOCHLOA OPHIUROIDES EXTRACT OR FRACTIONS THEREOF AS AN ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/712060
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712060
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712060 | Pharmaceutical composition for the prevention or treatment of alopecia comprising | Dec 11, 2019 | Issued |
Array
(
[id] => 18461453
[patent_doc_number] => 11685736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => P2X
[patent_app_type] => utility
[patent_app_number] => 16/704264
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 49484
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16704264
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/704264 | P2X | Dec 4, 2019 | Issued |
Array
(
[id] => 16420497
[patent_doc_number] => 20200345695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/700866
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700866
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700866 | Therapeutic agent for keratoconjunctive disorders | Dec 1, 2019 | Issued |
Array
(
[id] => 15676925
[patent_doc_number] => 20200093126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => COMPOSITION BASED ON NORDIHYDROGUAIARETIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/693330
[patent_app_country] => US
[patent_app_date] => 2019-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693330 | Composition based on nordihydroguaiaretic acid | Nov 23, 2019 | Issued |
Array
(
[id] => 16776411
[patent_doc_number] => 20210113488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => Paraffin Wax with CBD Isolate
[patent_app_type] => utility
[patent_app_number] => 16/660007
[patent_app_country] => US
[patent_app_date] => 2019-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16660007
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/660007 | Paraffin wax with CBD isolate | Oct 21, 2019 | Issued |
Array
(
[id] => 16125781
[patent_doc_number] => 10696630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Urea derivative or pharmacologically acceptable salt thereof
[patent_app_type] => utility
[patent_app_number] => 16/580909
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70015
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580909 | Urea derivative or pharmacologically acceptable salt thereof | Sep 23, 2019 | Issued |
Array
(
[id] => 15615935
[patent_doc_number] => 20200078372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => USE OF VANADIUM COMPOUNDS FOR MAINTAINING NORMAGLYCEMIA IN A MAMMAL
[patent_app_type] => utility
[patent_app_number] => 16/571953
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16571953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/571953 | Use of vanadium compounds for maintaining normaglycemia in a mammal | Sep 15, 2019 | Issued |
Array
(
[id] => 16336485
[patent_doc_number] => 10787429
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-09-29
[patent_title] => Products and methods of mechanical extraction and purification of tetrahydrocannabinolic acid
[patent_app_type] => utility
[patent_app_number] => 16/556128
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4374
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 273
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556128 | Products and methods of mechanical extraction and purification of tetrahydrocannabinolic acid | Aug 28, 2019 | Issued |
Array
(
[id] => 15342629
[patent_doc_number] => 20200009206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHOD FOR PREPARATION OF PHARMACOLOGICALLY-RELEVANT COMPOUNDS FROM BOTANICAL SOURCES
[patent_app_type] => utility
[patent_app_number] => 16/550150
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16550150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/550150 | Method for preparation of pharmacologically-relevant compounds from botanical sources | Aug 22, 2019 | Issued |